{"organizations": [], "uuid": "d29f86d785d1255201bc74d818543e159933db25", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180425.html", "section_title": "Archive News &amp; Video for Wednesday, 25 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-mologen-reaches-key-strategic-mile/brief-mologen-reaches-key-strategic-milestones-and-successfully-implements-capital-measures-in-2017-idUSASO0003SB", "country": "US", "domain_rank": 408, "title": "BRIEF-Mologen Reaches Key Strategic Milestones And Successfully Implements Capital Measures In 2017", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.071, "site_type": "news", "published": "2018-04-25T13:19:00.000+03:00", "replies_count": 0, "uuid": "d29f86d785d1255201bc74d818543e159933db25"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-mologen-reaches-key-strategic-mile/brief-mologen-reaches-key-strategic-milestones-and-successfully-implements-capital-measures-in-2017-idUSASO0003SB", "ord_in_thread": 0, "title": "BRIEF-Mologen Reaches Key Strategic Milestones And Successfully Implements Capital Measures In 2017", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "mologen ag", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 25 (Reuters) - Mologen AG:\n* DGAP-NEWS: MOLOGEN REACHED KEY STRATEGIC MILESTONES AND SUCCESSFULLY IMPLEMENTS CAPITAL MEASURES IN 2017\n* CONFIDENT OUTLOOK FOR FULL YEAR 2018 * CASH AND CASH EQUIVALENTS AMOUNTED TO EUR6.5 MILLION AS OF 31 DECEMBER 2017 (31 DECEMBER 2016: EUR20.5 MILLION)\n* IN 2017, RESEARCH AND DEVELOPMENT EXPENSES AT EUR14.0 MILLION AND WERE THEREFORE DOWN YEAR ON YEAR (PREVIOUS YEAR: EUR17.0 MILLION)\n* FY EBIT IMPROVED TO EUR-18.7 MILLION (PREVIOUS YEAR: EUR-21.0 MILLION) Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-25T13:19:00.000+03:00", "crawled": "2018-04-26T20:44:27.000+03:00", "highlightTitle": ""}